FRAMINGHAM (09/24/2003) - New to the instrument reagent system market is BenchMark XT from Ventana Medical Systems Inc. Designed for medium- to high-volume laboratories, BenchMark XT automates the baking, deparaffinization, cell conditioning, and staining processes (BTS technology) associated with diagnostic tissue testing.
According to the company, the new system eliminates more than 80 percent of the labor associated with other slide-staining systems. Ventana also says the BenchMark XT is the first system for anatomical pathology laboratories that allows users to simultaneously run immunohistochemistry (IHC) testing for protein detection and in situ Hybridization (ISH) and Fluorescent in situ Hybridization (FISH) testing for DNA and RNA detection, adding significant flexibility and throughput improvements.
Vendor: Ventana Medical Systems
Product Name: BenchMark XT
For more information: +1-(800) 227-2155; or www.ventanamed.com